These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22010136)

  • 1. Apolipoprotein isoform E4 does not increase coronary heart disease risk in carriers of low-density lipoprotein receptor mutations.
    Versmissen J; Oosterveer DM; Hoekstra M; Out R; Berbée JF; Blommesteijn-Touw AC; van Vark-van der Zee L; Vongpromek R; Vanmierlo T; Defesche JC; Mulder M; Kastelein JJ; Sijbrands EJ
    Circ Cardiovasc Genet; 2011 Dec; 4(6):655-60. PubMed ID: 22010136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update of the molecular basis of familial hypercholesterolemia in The Netherlands.
    Fouchier SW; Kastelein JJ; Defesche JC
    Hum Mutat; 2005 Dec; 26(6):550-6. PubMed ID: 16250003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial hypercholesterolemia and familial defective apolipoprotein B-100: comparison of the phenotypic expression In 116 cases.
    Brugger D; Schuster H; Zöllner N
    Eur J Med Res; 1996 May; 1(8):383-6. PubMed ID: 9360938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk in relation to functionality of sequence variants in the gene coding for the low-density lipoprotein receptor: a study among 29,365 individuals tested for 64 specific low-density lipoprotein-receptor sequence variants.
    Huijgen R; Kindt I; Defesche JC; Kastelein JJ
    Eur Heart J; 2012 Sep; 33(18):2325-30. PubMed ID: 22390909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The type of LDLR gene mutation predicts cardiovascular risk in children with familial hypercholesterolemia.
    Guardamagna O; Restagno G; Rolfo E; Pederiva C; Martini S; Abello F; Baracco V; Pisciotta L; Pino E; Calandra S; Bertolini S
    J Pediatr; 2009 Aug; 155(2):199-204.e2. PubMed ID: 19446849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
    Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
    J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting.
    Civeira F; Jarauta E; Cenarro A; García-Otín AL; Tejedor D; Zambón D; Mallen M; Ros E; Pocoví M
    J Am Coll Cardiol; 2008 Nov; 52(19):1546-53. PubMed ID: 19007590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mutation screening and functional analysis of low density lipoprotein receptor in a familial hypercholesterolemia family].
    Cheng XH; Zheng F; Zhou X; Xiong CL; Ding J; Chen YM
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):55-8. PubMed ID: 18247305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease.
    Tybjaerg-Hansen A; Steffensen R; Meinertz H; Schnohr P; Nordestgaard BG
    N Engl J Med; 1998 May; 338(22):1577-84. PubMed ID: 9603795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-density lipoprotein receptor gene mutation analysis and clinical correlation in Belgian hypercholesterolaemics.
    Van Gaal LF; Peeters AV; De Block CE; de Leeuw IH; Thiart R; Kotze MJ
    Mol Cell Probes; 2001 Dec; 15(6):329-36. PubMed ID: 11851376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of LDL-receptor mutation type on age at first cardiovascular event in patients with familial hypercholesterolaemia.
    Souverein OW; Defesche JC; Zwinderman AH; Kastelein JJ; Tanck MW
    Eur Heart J; 2007 Feb; 28(3):299-304. PubMed ID: 17090611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred.
    Takada D; Emi M; Ezura Y; Nobe Y; Kawamura K; Iino Y; Katayama Y; Xin Y; Wu LL; Larringa-Shum S; Stephenson SH; Hunt SC; Hopkins PN
    J Hum Genet; 2002; 47(12):656-64. PubMed ID: 12522687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia].
    Liu YR; Tao QM; Chen JZ; Tao M; Guo XG; Shang YP; Zhu JH; Zhang FR; Zheng LR; Wang XX
    Sheng Li Xue Bao; 2004 Oct; 56(5):566-72. PubMed ID: 15497035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of LDLR-negative genotype on CT coronary atherosclerosis in asymptomatic statin treated patients with heterozygous familial hypercholesterolemia.
    Ten Kate GJ; Neefjes LA; Dedic A; Nieman K; Langendonk JG; Galema-Boers AJ; Roeters van Lennep J; Moelker A; Krestin GP; Sijbrands EJ; de Feyter PJ
    Atherosclerosis; 2013 Apr; 227(2):334-41. PubMed ID: 23369702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of familial hypercholesterolemia in Spain: identification of 39 novel and 77 recurrent mutations in LDLR.
    Mozas P; Castillo S; Tejedor D; Reyes G; Alonso R; Franco M; Saenz P; Fuentes F; Almagro F; Mata P; Pocoví M
    Hum Mutat; 2004 Aug; 24(2):187. PubMed ID: 15241806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemia.
    Defesche JC; Pricker KL; Hayden MR; van der Ende BE; Kastelein JJ
    Arch Intern Med; 1993 Oct; 153(20):2349-56. PubMed ID: 8215738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mutations identification in exon 4 of LDLR gene in patients with moderate hypercholesterolemia in a Venezuelan population.
    Arráiz N; Bermúdez V; Rondon N; Reyes F; Borjas L; Solís E; Mujica E; Prieto C; Reyna N; Velasco M
    Am J Ther; 2010; 17(3):325-9. PubMed ID: 20019594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter by Singh et al regarding article, "Apolipoprotein isoform e4 does not increase coronary heart disease risk in carriers of low-density lipoprotein receptor mutations".
    Singh P; Di Napoli M; Singh M
    Circ Cardiovasc Genet; 2012 Apr; 5(2):e13; author reply e14. PubMed ID: 22511711
    [No Abstract]   [Full Text] [Related]  

  • 20. Spectrum of LDLR gene mutations, including a novel mutation causing familial hypercholesterolaemia, in North-western Greece.
    Diakou M; Miltiadous G; Xenophontos SL; Manoli P; Cariolou MA; Elisaf M
    Eur J Intern Med; 2011 Oct; 22(5):e55-9. PubMed ID: 21925044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.